Optimizing Pre-Exposure Prophylaxis (PrEP) Among Latino Men Who Have Sex With Men (MSM) in Puerto Rico

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age21-99
SponsorUniversity of Puerto Rico

About this trial

To develop, assess and compare the effectiveness of a Motivational Interviewing Intervention for increasing Pre-Exposure Prophylaxis (PrEP) uptake among Latino eligible men in Puerto Rico.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Biological male

Age 21 or older

Self-reported HIV negative or unknown status

Not using PrEP (participants who have discontinued PrEP use can participate in the study), Spanish fluency (ability to write and read in Spanish)

Disqualifiers

HIV positive individual

Evidence of being under the effects of alcohol or drugs

Indication of unstable or serious psychiatric symptoms

Evidence of major cognitive impairment

Trial design

Design model

Parallel

Treatments tested in this trial

  • Motivational Interviewing

    Behavioral

    Upon refinement from Formative Research (Aim 1), a three-session, individual-level intervention to increase Pre-Exposure Prophylaxis (PrEP) uptake among men who have sex with men (MSM) in Puerto Rico will be implemented. The facilitator will use Motivational Interviewing techniques to guide the sessions. The intervention's design and content will be the same for each study group; the only difference will be the modality of implementation; one group of participants will receive a face-to-face intervention, while another group will receive an online intervention.A total of 170 participants will be randomized in a 1:1 ratio into each of the two intervention modalities (n=85 face-to-face and n=85 online) while a control group will be recruited following a 3:1 ratio of intervention vs. control. In addition to baseline assessment, participants will be asked to complete a post test at the end of the third session (60 days) and a follow-up post-test at the 150-day mark, separately.

Treatment groups

182 Participants
are divided into 3 treatment groups
Group A: Face-to-face interventionExperimental treatment 1 intervention
Group B: Online interventionExperimental treatment 1 intervention
Group C: ControlNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Primary

PrEP uptake

Time frame
90 days

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.